The Journal of Immunology, Vol 153, Issue 3 938-945, Copyright © 1994 by American Association of Immunologists

ARTICLES

Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation

G Benichou, E Fedoseyeva, PV Lehmann, CA Olson, HM Geysen, M McMillan and EE Sercarz
Department of Microbiology and Molecular Genetics, University of California-Los Angeles 90024.

Previously, we have demonstrated that during allograft rejection, MHC molecules of the donor are processed and presented to alloreactive CD4+ T lymphocytes in the form of peptides associated with the MHC class II molecules of the recipient. There is an increasing body of evidence that this indirect pathway of allorecognition may play a major role in allograft rejection. Herein, we have used a series of overlapping MHC peptides progressing along the sequence of the donor MHC molecule in single residue steps. We have mapped all potential MHC Ag determinants to which T cell responses could be generated after s.c. injection of allogeneic splenocytes. We have shown that splenic T cell proliferative responses to the beta 1 domains of donor Ak, Ad, and A(s) mouse MHC class II molecules were directed toward a single immunodominant determinant in each of three donor/recipient combinations. Interestingly, after allogeneic spleen cell transplantation, an additional determinant on donor MHC could be detected in the draining lymph nodes. This result shows that the fine specificity of T cell response to donor transplantation Ags can differ between lymphoid organs. Then, we investigated whether limitation of T cell response to donor MHC peptides applies to the clinical situation of a graft. We have shown that after an allogeneic skin graft, self-restricted alloreactive T cells proliferated to the same determinant on the donor MHC molecule. These results indicate that immune intervention, such as tolerance induction to the dominant T cell determinant on donor MHC molecules, may be developed for the prevention of allograft rejection.

This article has been cited by other articles:

				A. Valujskikh, Q. Zhang, and P. S. Heeger CD8 T Cells Specific for a Donor-Derived, Self-Restricted Transplant Antigen Are Nonpathogenic Bystanders after Vascularized Heart Transplantation in Mice J. Immunol., February 15, 2006; 176(4): 2190 - 2196. [Abstract] [Full Text] [PDF]

				K. L. WOMER, J. R. STONE, B. MURPHY, A. CHANDRAKER, and M. H. SAYEGH Indirect Allorecognition of Donor Class I and II Major Histocompatibility Complex Peptides Promotes the Development of Transplant Vasculopathy J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2500 - 2506. [Abstract] [Full Text] [PDF]

				E. Lovegrove, G. J. Pettigrew, E. M. Bolton, and J. A. Bradley Epitope Mapping of the Indirect T Cell Response to Allogeneic Class I MHC: Sequences Shared by Donor and Recipient MHC May Prime T Cells That Provide Help for Alloantibody Production J. Immunol., October 15, 2001; 167(8): 4338 - 4344. [Abstract] [Full Text] [PDF]

				F. Boisgerault, Y. Liu, N. Anosova, E. Ehrlich, M. R. Dana, and G. Benichou Role of CD4+ and CD8+ T Cells in Allorecognition: Lessons from Corneal Transplantation J. Immunol., August 15, 2001; 167(4): 1891 - 1899. [Abstract] [Full Text] [PDF]

				G. Benichou, A. Valujskikh, and P. S. Heeger Contributions of Direct and Indirect T Cell Alloreactivity During Allograft Rejection in Mice J. Immunol., January 1, 1999; 162(1): 352 - 358. [Abstract] [Full Text] [PDF]

				D. Matesic, A. Valujskikh, E. Pearlman, A. W. Higgins, A. C. Gilliam, and P. S. Heeger Type 2 Immune Deviation Has Differential Effects on Alloreactive CD4+ and CD8+ T Cells J. Immunol., November 15, 1998; 161(10): 5236 - 5244. [Abstract] [Full Text] [PDF]

				P. A. Smith, A. Brunmark, M. R. Jackson, and T. A. Potter Peptide-independent Recognition by Alloreactive Cytotoxic T Lymphocytes (CTL) J. Exp. Med., March 17, 1997; 185(6): 1023 - 1034. [Abstract] [Full Text] [PDF]